- Redx Pharma said CFO Phil Tottey will be stepping down from the board and leaving the Company on 30 September 2016 to pursue new opportunities.

Andrew Booth, presently Financial Controller, would act as Interim Finance Director pending a permanent appointment.

At the same time, the Board is pleased to welcome Karl Hard to the Executive Management Team as Head of Investor Relations and Corporate Communications.

At 11:17am: [LON:REDX] Redx Pharma Plc Ord 1p share price was 0p at 26.5p

Story provided by